Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Conavi Medical Corp T.TMD

Healthcare Medical Devices
Conavi Medical Corp., formerly Titan Medical Inc., is a Canada-based company. The Company is focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. The Novasight Hybrid System is intended for intravascular imaging of coronary arteries and is indicated in patients who are candidates for transluminal interventional procedures. Its Novasight Hybrid System combines both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) to enable simultaneous and co-registered imaging of coronary arteries. Hybrid IVUS and OCT imaging provides additional information over single modality imaging in complex lesions. The versatility of hybrid imaging is useful for a variety of complex percutaneous coronary intervention (PCIs), including situations where the customer may want to image large ostial lesions with IVUS but also use OCT for diseased distal lesions and/or stent assessment.


TSX:TMD - Post by User

Conavi Medical Corp > Titan is Piling Up the Patents what's it's Worth?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by happyraton Nov 11, 2021 2:59pm
289 Views
Post# 34116382

RE:Titan is Piling Up the Patents what's it's Worth?

RE:Titan is Piling Up the Patents what's it's Worth?Today it's apparently worth a buck fifty a share :)

I've held this share for half a decade and I'm no shrinking sally when it comes to quitting when times are tough.  This is one to leave your grandkids, not to pay for next year's Porsche.

I've seen numbers between 40 cents and 4 bucks a share and I've always hung in for the long payoff.

I can understand that they want to refine the hell oiut of the technology before they start anything resembling production.

At least the Medtreonic Licensing deal eased the cash burn for the past year or so.

Today, the market is reacting to the postponement of a few deadlines (milestones?) for another year.

They had a hell of a sales pitch even 5 years ago and we're holding a share of the development costs.

If it takes off ianytime n this decade I should be happy enough.




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities